Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan B Switch NDA Could Be Supported By New Study Findings

This article was originally published in The Tan Sheet

Executive Summary

Study results indicating a single 1.5 mg dose of levonorgestrel is as effective as two .75 mg doses 12 hours apart could help Women's Capital Corp. in its attempt to switch its emergency contraceptive Plan B over-the-counter

You may also be interested in...



OTC Emergency Contraceptive Application Nearing FDA Panel Review

Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December

OTC Emergency Contraceptive Application Nearing FDA Panel Review

Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December

OTC Emergency Contraceptive Application Nearing FDA Panel Review

Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel